Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Medicinal Chemistry|February 3, 2023
Discovery of novel and bioavailable histone deacetylases and cyclin-dependent kinases dual inhibitor to impair the stemness of leukemia cellsYulin Liu, Yujiao Wei, Xuan Wang, et al.
European Journal of Medicinal Chemistry|August 22, 2020
Design and synthesis of novel Flavone-based histone deacetylase inhibitors antagonizing activation of STAT3 in breast cancerMingming Wei, Maodun Xie, Zhen Zhang, et al.
Bioorganic & Medicinal Chemistry|February 22, 2023
Structure optimization and discovery of novel compound for the treatment of insertion mutations within exon 20 of EGFR and HER2Yetong Cui, Ruonan Wang, Yujiao Wei, et al.
European Journal of Medicinal Chemistry|December 1, 2020
First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivoMingming Wei, Rui Zhao, Yuting Cao, et al.
Bioorganic & Medicinal Chemistry|July 10, 2023
Design and discovery of new selective and potent VEGF receptor 2 tyrosine kinase inhibitorsFei Hou, Yuhong Yao, Yujiao Wei, et al.
European Journal of Medicinal Chemistry|July 18, 2020
Design and synthesis of Leukotriene A4 hydrolase inhibitors to alleviate idiopathic pulmonary fibrosis and acute lung injuryXiaohe Li, Maodun Xie, Cheng Lu, et al.
Journal of Medicinal Chemistry|November 16, 2018
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic AcidsXinhua Liu, Benlong Li, Zhen Zhang, et al.
European Journal of Medicinal Chemistry|August 11, 2018
Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-β1 pathwayXiaohe Li, Cheng Lu, Shuangwei Liu, et al.
Pageof 2